July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration
Author Affiliations & Notes
  • Katherine Grace Chen
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Jason Alvarez
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Wai T Wong
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Henry Wiley
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Emily Y. Chew
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Frederick L Ferris
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Catherine A Cukras
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Katherine Chen, None; Jason Alvarez, None; Wai Wong, None; Henry Wiley, None; Emily Chew, None; Frederick Ferris, None; Catherine Cukras, None
  • Footnotes
    Support  National Eye Institute Intramural Research Program, National Institutes of Health (NIH), Bethesda, Maryland; and the NIH Medical Research Scholars Program
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2423. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katherine Grace Chen, Jason Alvarez, Wai T Wong, Henry Wiley, Emily Y. Chew, Frederick L Ferris, Catherine A Cukras; Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2423.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess for correlation of changes in dark adaptation (DA) with age-related macular degeneration (AMD) severity, presence of reticular pseudodrusen (RPD), and progression of fundus features over 4 years.

Methods : Participants >50 years of age were assigned into groups based on fundus features: no large drusen (Group 0), unilateral large drusen (Group 1), bilateral large drusen (Group 2), late AMD in one eye with large drusen in fellow eye (Group 3), presence of RPD regardless of AMD status (Group RPD). Study eyes were also graded using the 9-step Age-Related Eye Disease Study (AREDS) Severity Scale. Study eyes underwent DA testing using a prototype AdaptDx™ device (MacuLogix, Hummelstown, PA) at baseline, 3, 6, 12, 18, 24, 36, and 48 months. The slope of the rod intercept time (RIT), or the rate of change in RIT (time for recovery to a stimulus intensity of 5 x 10-3 cd/m2), was calculated by linear regression fits of each individual’s RIT data. The slope RITs for AMD categories were compared using nonparametric statistical testing.

Results : A total of 75 eyes in 75 participants (mean age 72±8.3 years, 53% female) were analyzed. All groups demonstrated a significantly positive slope RIT (p<0.0001 compared to the horizontal), indicating a prolongation of RIT over time. We found a trend of increasing rate of RIT change with increasing baseline AMD severity (mean rates for Groups 0-3 were 0.67, 0.72, 1.1, 2.2 min/year respectively) despite stable visual acuity. This trend was also present when study eyes were grouped using the AREDS Severity Scale. Eyes with RPD at baseline tested using an alternate testing protocol also demonstrated significantly positive slope RIT (mean RIT change = 2.83 mins/year). Study eyes without RPD at baseline that developed RPD during the study had a significantly greater mean baseline RITs (29.50 vs 14.65 mins, p<0.0001) and greater mean slope RITs (2.89 vs 0.74 mins/year, p<0.0001) than those that never develop RPD. Study eyes that exhibited progression of fundus changes (≥2 steps) on the AREDS Severity Scale trended towards a higher slope RIT but was not statistically significant.

Conclusions : DA as measured by RIT progressively worsens over the course of 4 years. Eyes with RPD at baseline and those that developed RPD demonstrate the greatest decrement in DA function. DA may be a useful functional parameter to understand AMD disease progression.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×